Nuvation Bio (NUVB) Competitors $2.31 +0.08 (+3.59%) Closing price 08/4/2025 03:59 PM EasternExtended Trading$2.32 +0.01 (+0.43%) As of 08/4/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUVB vs. AAPG, HCM, KYMR, CRNX, IMVT, ALVO, MOR, OGN, NAMS, and RXRXShould you be buying Nuvation Bio stock or one of its competitors? The main competitors of Nuvation Bio include Ascentage Pharma Group International (AAPG), HUTCHMED (HCM), Kymera Therapeutics (KYMR), Crinetics Pharmaceuticals (CRNX), Immunovant (IMVT), Alvotech (ALVO), MorphoSys (MOR), Organon & Co. (OGN), NewAmsterdam Pharma (NAMS), and Recursion Pharmaceuticals (RXRX). These companies are all part of the "pharmaceutical products" industry. Nuvation Bio vs. Its Competitors Ascentage Pharma Group International HUTCHMED Kymera Therapeutics Crinetics Pharmaceuticals Immunovant Alvotech MorphoSys Organon & Co. NewAmsterdam Pharma Recursion Pharmaceuticals Ascentage Pharma Group International (NASDAQ:AAPG) and Nuvation Bio (NYSE:NUVB) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends. Which has preferable valuation and earnings, AAPG or NUVB? Ascentage Pharma Group International has higher revenue and earnings than Nuvation Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAscentage Pharma Group International$134.35M24.42-$55.54MN/AN/ANuvation Bio$7.87M99.87-$567.94M-$2.35-0.98 Do analysts recommend AAPG or NUVB? Nuvation Bio has a consensus price target of $7.17, suggesting a potential upside of 210.25%. Given Nuvation Bio's stronger consensus rating and higher possible upside, analysts clearly believe Nuvation Bio is more favorable than Ascentage Pharma Group International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ascentage Pharma Group International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Nuvation Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Do institutionals & insiders hold more shares of AAPG or NUVB? 61.7% of Nuvation Bio shares are held by institutional investors. 29.9% of Nuvation Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is AAPG or NUVB more profitable? Ascentage Pharma Group International has a net margin of 0.00% compared to Nuvation Bio's net margin of -5,534.21%. Ascentage Pharma Group International's return on equity of 0.00% beat Nuvation Bio's return on equity.Company Net Margins Return on Equity Return on Assets Ascentage Pharma Group InternationalN/A N/A N/A Nuvation Bio -5,534.21%-44.14%-32.97% Does the media prefer AAPG or NUVB? In the previous week, Nuvation Bio had 8 more articles in the media than Ascentage Pharma Group International. MarketBeat recorded 9 mentions for Nuvation Bio and 1 mentions for Ascentage Pharma Group International. Ascentage Pharma Group International's average media sentiment score of 0.58 beat Nuvation Bio's score of 0.18 indicating that Ascentage Pharma Group International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ascentage Pharma Group International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nuvation Bio 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral SummaryNuvation Bio beats Ascentage Pharma Group International on 8 of the 14 factors compared between the two stocks. Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUVB vs. The Competition Export to ExcelMetricNuvation BioMED IndustryMedical SectorNYSE ExchangeMarket Cap$758.79M$3.02B$5.51B$20.47BDividend YieldN/A2.46%4.74%3.70%P/E Ratio-0.9818.0629.1429.36Price / Sales99.87272.86435.0566.69Price / CashN/A40.5624.4817.52Price / Book1.698.628.524.62Net Income-$567.94M-$54.98M$3.24B$993.83M7 Day Performance-5.91%-0.87%0.65%-1.79%1 Month Performance10.79%16.08%7.97%-1.30%1 Year Performance-27.24%14.18%30.98%15.88% Nuvation Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUVBNuvation Bio2.013 of 5 stars$2.31+3.6%$7.17+210.2%-31.3%$758.79M$7.87M-0.9860Upcoming EarningsAAPGAscentage Pharma Group InternationalN/A$39.27+3.9%N/AN/A$3.30B$134.35M0.00600HCMHUTCHMED3.2299 of 5 stars$17.98+2.1%$23.50+30.7%-4.7%$3.07B$630.20M0.001,811Positive NewsUpcoming EarningsKYMRKymera Therapeutics3.569 of 5 stars$44.20-3.5%$59.11+33.7%+3.9%$2.98B$47.07M0.00170Positive NewsUpcoming EarningsCRNXCrinetics Pharmaceuticals3.3415 of 5 stars$30.30-2.2%$69.50+129.4%-43.3%$2.90B$1.04M0.00210Positive NewsUpcoming EarningsIMVTImmunovant1.6227 of 5 stars$16.76-1.1%$36.40+117.2%-42.3%$2.90BN/A0.00120ALVOAlvotech3.884 of 5 stars$9.81+2.1%$14.00+42.7%-23.1%$2.90B$491.98M16.571,032Positive NewsGap UpMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730OGNOrganon & Co.4.8341 of 5 stars$9.96-2.4%$18.00+80.7%-53.7%$2.65B$6.40B2.824,000NAMSNewAmsterdam Pharma3.3639 of 5 stars$23.42-0.8%$41.30+76.3%+27.3%$2.65B$45.56M0.004Positive NewsUpcoming EarningsRXRXRecursion Pharmaceuticals1.3842 of 5 stars$6.31-2.8%$7.00+10.9%-17.4%$2.64B$58.84M0.00400Gap Up Related Companies and Tools Related Companies Ascentage Pharma Group International Alternatives HUTCHMED Alternatives Kymera Therapeutics Alternatives Crinetics Pharmaceuticals Alternatives Immunovant Alternatives Alvotech Alternatives MorphoSys Alternatives Organon & Co. Alternatives NewAmsterdam Pharma Alternatives Recursion Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NUVB) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NUVB Stock Alerts